Clinical Trial Detail

NCT ID NCT02859454
Title Avelumab for People With Recurrent Respiratory Papillomatosis
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

papilloma

Therapies

Avelumab

Age Groups: senior adult

No variant requirements are available.